Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Necrobiosis Lipoidica
Interventions: PCS499, placebo; Drug · Other
Lead sponsor: Processa Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: San Diego, California • Rochester, Minnesota • Charleston, South Carolina + 1 more

Conditions: Diabetic Foot Ulcer
Interventions: Offloading Boot; Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Downey, California • Glendale, California • Los Angeles, California

Conditions: Venous Stasis Ulcers
Interventions: Fish Oil; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetic Foot Ulcers
Interventions: AutoloGel; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Arcadia, California • Cumming, Georgia

Conditions: IBD, Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Ultra Processed Food, Nutrition Assessment, DGBI
Interventions: Handout-Only Intervention, Handout + Video Intervention; Behavioral
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 10 Years to 21 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Corneal Ulcer, Infectious Keratitis, Bacterial Ulcer, Fungal Ulcer
Interventions: Corneal Cross-linking, Anti Fungal Drug; Procedure · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ulcerative Colitis
Interventions: Soluble protein hydrolysate (SPHi); Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 7 Years to 18 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Diabetic Foot Ulcer
Interventions: CDO electrochemical tissue oxygenation system, Moist Wound Therapy; Device
Lead sponsor: Electrochemical Oxygen Concepts, Inc.; Industry
Eligibility: 30 Years to 90 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 33
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 25 more

Conditions: Ulcerative Colitis (UC)
Interventions: Not listed
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 8,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 170
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 133 more

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Ulcer Foot, Leg Ulcer
Interventions: Standard of Care-DFU, AmnioCore - DFU, Amnio Quad-Core - DFU, Standard of Care-VLU, Amnio Tri-Core - VLU, Amniocore Pro +; Other
Lead sponsor: Stability Biologics; Industry
Eligibility: 21 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Circleville, Ohio

Conditions: Aortic Aneurysm, Thoracic, Penetrating Ulcer
Interventions: RelayPro; Device
Lead sponsor: Bolton Medical; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 24
States / cities: Birmingham, Alabama • Phoenix, Arizona • Irvine, California + 17 more

Conditions: Ulcerative Colitis Mild, Ulcerative Colitis
Interventions: BRS201, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Ulcerative Colitis, Pouchitis
Interventions: ursodiol (ursodeoxycholic acid, UDCA); Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ulcerative Colitis
Interventions: Nicotinamide Riboside Chloride, Placebo, Standard of Care; Dietary Supplement · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: Up to 18 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spinal Cord Injury
Interventions: Daily telephone calls, Weekly telephone calls; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Hines, Illinois • Cleveland, Ohio

Conditions: Keratitis Bacterial, Corneal Ulcer (Diagnosis)
Interventions: Adjunctive Topical Fluorometholone (FML) 0.1%, Standard Topical Antibiotic Therapy; Drug
Lead sponsor: Vishal Jhanji; Other
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Interventions: Biopsy strategy; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 1,642 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 21
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 15 more

Conditions: Diabetic Foot Ulcer
Interventions: Folinic acid calcium salt; Combination Product
Lead sponsor: Joseph Boykin, MD; Federal
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Diabetic Foot Infection, Diabetic Foot
Interventions: Topical Pravibismane, Standard of Care; Drug · Other
Lead sponsor: Microbion Corporation; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Fresno, California • Dallas, Texas • McAllen, Texas + 1 more

Conditions: Diabetic Foot Ulcers
Interventions: Moist Wound Therapy, VAC Therapy; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 24
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 17 more

Conditions: Ulcerative Colitis
Interventions: SAR339658; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 5
States / cities: Mission Hills, California • Miramar, Florida • Winter Park, Florida + 2 more

Conditions: Venous Leg Ulcer, Chronic Non-Healing Cutaneous Wounds, VLU
Interventions: LUT017 gel; Drug
Lead sponsor: Antoni Ribas; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative
Interventions: MORF-057, Placebo; Drug
Lead sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company); Industry
Eligibility: 18 Years to 85 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 8
States / cities: Sun City, Arizona • Lancaster, California • Los Angeles, California + 5 more

Conditions: Upper Gastrointestinal Bleeding, Peptic Ulcer Hemorrhage, Anticoagulant-induced Bleeding
Interventions: Clinician Notification with Nurse Facilitation (CNNF), Wait list control; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 341 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica

Smart Boot Use to Measure Offloading Adherence

Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers

Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Cross-linking for Corneal Ulcers Treatment Trial

Pilot Study of a New Medical Food in the Management of Ulcerative Colitis

A Prospective, Randomized, Double-Blind Multicenter Study Comparing CDO Therapy to Standard MWT in the Treatment of DFUs

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers

Treatment of UC With Novel Therapeutics

The Role of Secondary Bile Acids in Intestinal Inflammation

Nicotinamide Riboside in Ulcerative Colitis

Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D

Fluorometholone Study

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Evaluation of a Folic Acid Wound Treatment (FAWT) for Chronic, Early-Stage Diabetic Foot Ulcer (DFU) Healing

Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients

Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

Anticoagulation With Enhanced Gastrointestinal Safety